3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Pancreatic Adenocarcinoma
1
Pain, Postoperative
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Hypotension
1
Cognitive Dysfunction
1
Chronic Pain
1
Breast Carcinoma In Situ
1
Agnosia
1
Acute Pain
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Anesthesia, General
×
1 year
×
Clear all
No trials found.